Online event

25 07-2023

Registration now open for the Rethinking Alzheimer’s disease virtual event

Dominika Suchonova2023-09-06T14:45:31+00:0025-07-2023|News|

Registration is now open for the virtual event Rethinking Alzheimer’s disease: Moving towards a new Alzheimer’s disease detection and diagnosis pathway in Sweden, taking place virtually on 26 September 2023 at 09:00 – 11:00. The European Brain Council (EBC), in collaboration with the European Federation of Pharmaceutical Industries and Associations (EFPIA), the Swedish Brain Foundation (SBF) and the Swedish Association [...]

13 06-2023

Save the date launches for Rethinking Alzheimer’s disease virtual event

Dominika Suchonova2023-09-06T14:44:03+00:0013-06-2023|News|

Save the date for the virtual event Rethinking Alzheimer’s disease: Moving towards a new Alzheimer’s disease detection and diagnosis pathway in Sweden, set to take place on 26 September 2023 at 10:00 – 12:00 (Brussels time)! About Alzheimer’s disease Alzheimer’s disease (AD) is a neurodegenerative disease that progresses in stages, beginning with a long silent phase [...]

8 12-2022

Registration now open for the launch event of the RETHINKING Alzheimer’s disease White Paper

Dominika Suchonova2023-01-10T12:03:16+00:0008-12-2022|News|

Registration is now open for the launch event of the RETHINKING Alzheimer's disease White Paper, taking place virtually on 24 January 2023 at 12:30 – 14:00. The European Brain Council (EBC), in collaboration with the European Federation of Pharmaceutical Industries and Associations (EFPIA), will present its White Paper “RETHINKING Alzheimer’s disease: Detection and diagnosis“. This paper [...]

24 11-2022

Save the date for the launch event of the RETHINKING Alzheimer’s disease White Paper!

Dominika Suchonova2023-01-10T13:12:36+00:0024-11-2022|News|

The launch event of the RETHINKING Alzheimer's disease White Paper, calling for change in Alzheimer's care, will take place virtually on 24 January 2023 at 12:30 - 14:00. About Alzheimer's disease Alzheimer’s disease (AD) is a neurodegenerative disease that progresses in stages, beginning with a long silent phase before symptoms occur. It is the underlying cause [...]